Summary
🔬 What if your MRI could do exponentially more than produce black-and-white images?
🧠 StartUp Health community members Valerie Gharagouzloo, CEO & Co-founder, and Codi Gharagouzloo, PhD, Chief Science Officer & Co-founder of Imaginostics, are building a first-of-its-kind vascular intelligence platform that replaces toxic contrast agents with a safer alternative and unlocks quantitative biomarkers that have never before been measurable at the individual patient level.
🏆 With FDA Breakthrough Designation in hand, a commercialization partnership with Siemens underway, and a 96-patient Alzheimer's biomarker study now in motion, Imaginostics is closing the distance between laboratory invention and bedside impact.
💡 In this conversation with StartUp Health Co-founder Unity Stoakes, Valerie and Codi share how their two platforms, ImagiView™ and ImagiSight™, are setting new benchmarks in safer, higher-quality imaging and precision vascular diagnostics, what it means to build a zero-to-one technology, and why the moment to pay attention to Imaginostics is right now.
🌐 Learn more
Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is available to StartUp Health Members. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.
👉 Learn more and join today.
